| Name | (1α,1'S,4β)-Lanabecestat |
|---|---|
| Synonyms |
(1α,1'S,4β) Lanabecestat,(1α,1'S,4β)Lanabecestat
(1Alpha,1'S,4Beta)-Lanabecestat (1α 4β)-AZD (1α,1'S,4β)-AZD Dispiro[cyclohexane-1,2'-[2H]indene-1'(3'H),2''-[2H]imidazol]-4''-amine, 4-methoxy-5''-methyl-6'-[5-(1-propyn-1-yl)-3-pyridinyl]-, (1α,1'S,4β) 4β)-Lanabecestat |
| Description | (1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) is a Beta site APP Cleaving Enzymel (BACE1) inhibitor extracted from patent WO2012087237A1, compound 20a, has IC50s of 2.2 nM (TR-FRET assay) and 0.28 nM (sAPPp release assay), respectively[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Gabor Csjernyik, et al. Compounds and their use as bace inhibitors. WO2012087237A1. |
| Molecular Formula | C26H28N4O |
|---|---|
| Molecular Weight | 412.53 |